本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioNTech SE

101.81
+3.053.09%
盘前101.24-0.5700-0.56%07:07 EDT
成交量:97.83万
成交额:9,925.77万
市值:244.31亿
市盈率:-35.50
高:102.99
开:97.50
低:97.30
收:98.76
数据加载中...
2024/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

关联方拟减持公告

Form 144 | BioNTech 大股东 ATHOS KG 拟减持55605股,总价约693万美元
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 | BioNTech SE 10%股东 ATHOS KG 拟减持50万股,总价约6170万美元
2024/09/16

关联方拟减持公告

Form 144 | BioNTech SE 股东 ATHOS KG 拟减持90000股,总价约1134万美元
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities